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Abstract  
 
Transcutaneous electrical nerve stimulation (TENS) is a non-pharmacological modality 
commonly used to relieve pain. To date, the efficacy of TENS remains poorly documented in 
elderly individuals. In this randomized, double-blind, cross-over study, we compared the efficacy 
of high-frequency (HF), low-frequency (LF) and placebo (P) TENS in a group of 15 elderly 
adults (mean age 67 ± 5 years). The effect of HF, LF and P-TENS was also evaluated in a group 
of 15 young individuals (26 ± 5 years; same study design) to validate the effectiveness of the 
TENS protocols that were used in the elderly group. Each participant came to the laboratory on 
three separate occasions to receive, in random order, HF, LF and P-TENS. Experimental pain 
was evoked with a 10 cm
2
 thermode applied on the lumbar spinal area for two minutes, during 
which subjects were asked to assess their pain with a computerized visual analogue scale. For the 
young group, there was a significant decrease in pain during and after HF and LF-TENS when 
compared to baseline, with both HF and LF-TENS being superior to P-TENS. In the older group, 
HF and LF-TENS did not reduce pain when compared to baseline, and no difference was 
observed between the two active TENS sessions and P-TENS. Our results suggest that HF and 
LF-TENS are effective in young, but not in older individuals. Future studies should be conducted 
to confirm these results in pain populations and to identify strategies that could enhance the effect 
of TENS in the elderly. 
 
 
 
1. Introduction 
 
Chronic pain is a prevalent healthcare condition, affecting approximately 100 million 
adults in the United States [14]. The prevalence of chronic pain significantly increases with age, 
with more than 50% of elderly people reporting persistent pain [23,51,59]. According to the 
American Geriatrics Society, seniors suffering from persistent pain should receive both 
pharmacological and non-pharmacological treatment options [1]. However, the efficacy of many 
non-pharmacological approaches used today in older individuals has yet to be confirmed [50]. 
 
Transcutaneous electrical nerve stimulation (TENS) is a non-pharmacological modality 
that is commonly used in rehabilitation to reduce pain [54]. The most common TENS stimulation 
parameters used are high frequency, low intensity stimulations (> 10 Hz, comfortable intensity; 
HF-TENS) and low frequency, high intensity stimulations (< 10 Hz, strong intensity; LF-TENS) 
[13,24]. HF-TENS stimulations allow the depolarization of Aβ fibers, producing segmental 
analgesia via gate-control mechanisms [19,44]. On the other hand, the strong stimulations 
induced by LF-TENS depolarize Aδ and C fibers and decrease pain via activation of descending 
pain modulating mechanisms originating from the brainstem [20,25,39,62]. Both HF and LF-
TENS produce their hypoalgesic effect via the release of endogenous opioids, with δ opioid 
receptors mediating the hypoalgesia of HF-TENS and µ opioid receptor mediating the 
hypoalgesia of LF-TENS [28,30,53,56].  
 
Past studies have shown that TENS can help reduce pain [6,24], analgesic consumption 
and the medication related side-effects [7,18]. These advantages are of particular interest for 
clinicians working with the elderly, a portion of the population who are often heavily medicated 
and prone to pharmacological side-effects [3,52]. Unfortunately, studies looking into the clinical 
efficacy of TENS are mainly performed on young adults or on age-heterogeneous populations, 
and the clinical efficacy of TENS in the elderly population remains poorly documented. To our 
knowledge, very few studies have specifically evaluated the hypoalgesic effect of TENS in 
elderly participants (see for instance [9,22,47]). Although interesting, these studies have 
important limitations (absence of placebo condition, incomplete description of the study’s 
population or of the TENS treatments), hence precluding any final conclusion that can be made 
regarding the efficacy of TENS in elderly people. The aim of the present study was to fill this 
knowledge gap and determine if TENS is an effective treatment option for older individuals. 
More specifically, the objective was to compare the efficacy of HF, LF and placebo (P) TENS in 
a group of elderly individuals. The effect of HF, LF and P-TENS was also evaluated in a group of 
young participants to validate the effectiveness of the TENS protocols that were used in this 
study. 
 
2. Methods 
 
2.1 Participants  
 
Fifteen young adults aged between 21-39 years (mean age 26 ± 5 years; 6 men) and 
fifteen older adults aged between 58-74 years (mean age 67 ± 5 years; 6 men) were included in 
the study. Participants were excluded if they were pregnant and/or had a pacemaker (TENS 
contraindications), used opioids in the last 6 months [29,55] or if they had an existing 
neurological or pain condition affecting the lumbar region. Every participant was asked to refrain 
from consuming caffeine [42]and short-term analgesics six hours before testing and tobacco 
products two hours before testing. The experiment took place at the Research Center on Aging of 
the Health and Social Services Center - University Institute of Geriatrics of Sherbrooke 
(Sherbrooke, Quebec, Canada). Subjects were recruited through local ads and were all French-
speaking community-dwelling individuals. The study was approved by the local institutional 
ethics committee and each participant provided informed written consent before participating in 
the study.  
 
2.2 Experimental design  
 
A double-blind placebo-controlled crossover design was used. Volunteers received three 
interventions, during three separate sessions (1 week interval), in random order: (1) HF-TENS, 
(2) LF-TENS and (3) placebo TENS (P-TENS). Randomization was performed using a random 
numbers table, controlling for presentation order. Controlling for presentation order ensured that 
an equal number of participants were randomized to each possible permutation level. Each time, 
the tonic heat pain test was performed on four occasions: (1) at baseline (T0), (2) during TENS 
(after 15 minutes of TENS stimulation; T1), (3) immediately after TENS (T2) and (4) 30 minutes 
after TENS application (T3). Heat pain thresholds (HPT) were also measured at baseline, during 
TENS (after 15 minutes of TENS stimulation) and immediately after TENS to evaluate the effect 
of TENS on pain sensitivity. 
 
2.3 Tonic heat pain model  
 
Participants were seated comfortably in a massage chair (see Figure 1). A pre-testing 
session was first carried out in order to familiarize participants with the computerized visual 
analogue scale (CoVAS; Medoc, Advanced Medical Systems, Minneapolis) and to determine the 
temperature that would be used during the two minutes tonic heat pain test. This pre-test was 
performed with a 10 cm
2
 Peltier-type thermode (Medoc, Advanced Medical Systems, 
Minneapolis) applied to the thoracic region. Participants were advised that the thermode 
temperature would gradually rise from 32 °C to 51 °C (rising rate = 0.3 °C/s). During the first 
pre-test, subjects verbally reported their pain perception threshold and pain tolerance threshold. 
On the second pre-test, subjects were given the CoVAS and advised that they would have to start 
moving the cursor towards the right (towards the “100” mark) when they would start to feel pain 
(pain perception threshold) and that the cursor would need to be at the extreme right (at the “100” 
mark) when pain was intolerable (pain tolerance threshold). This procedure was repeated until the 
subject's pain reports were consistent between trials. The temperature used during the following 
experimental heat pain test was determined by selecting the temperature for which the subject 
had rated the pain intensity at 50/100 (moderate pain) with the CoVAS (see Leonard et al. [30] 
for a similar approach). The decision to use a test stimulus that would produce moderate levels of 
pain was based on the observations of Benedetti et al. [5] who reported that TENS is effective for 
mild or moderate pain, but not for severe pain.  
 
 Following the pre-test, participants were given a 10 minutes rest period before the 
experimental test began. The tonic pain test was performed with the application of the thermode 
at a constant temperature applied on the lumbar region for 2 minutes. Subjects were told that the 
thermode temperature could rise, remain stable or decrease and that they would need to evaluate 
their pain with the CoVAS throughout the 2 minutes of the test. In fact, after a constant rise 
(1 °C/s) from baseline (32 °C) to the individually predetermined temperature, the thermode's 
temperature remained constant throughout the times of the test. 
 
2.4 Heat pain threshold (HPT) 
 
HPT were evaluated in the lumbar region with the Peltier-type thermode. The threshold 
was determined using the method of limits [45,63]. Participants were advised that the temperature 
of the thermode would gradually increase and that they would need to report their first pain 
sensation by clicking on the left button of a computer mouse (baseline = 32 °C; rising rate = 
1 °C/sec). A total of three HPT values were taken at each time measure. The three values of the 
same time measure were then averaged to obtain a single HPT value.  
 
2.5 TENS stimulation protocol  
 
For each visit, TENS stimulations were delivered using two pairs of rubber silicone 
electrodes connected to a digital Eclipse Plus apparatus (Empi®, St-Paul, Minnesota). Electrodes 
were placed on the lower thoracic and lumbar region (see Figure 1). For HF-TENS, the frequency 
was set at 100 Hz, the pulse duration at 60 μs and the intensity was adjusted to produce strong 
and comfortable (innocuous) tingling sensations [38,39,61]. For the LF-TENS, the frequency was 
set at 3 Hz, the pulse duration at 400 μs and the intensity was adjusted to produce strong and 
painful sensations [38,39,61]. For the P-TENS, the frequency was set at 100 Hz, the pulse 
duration at 60 μs. However, the TENS apparatus was turned ‘‘OFF’’ using a hidden device which 
disabled the electrodes without changing the display on the equipment (electric stimulation 
applied to built-in resistors). The participants were led to believe that there was an electric current 
(indication of stimulation on the TENS device) but in reality, electric current was dissipated as 
heat in the resistors (no electrical stimulation given to the participants). For all TENS conditions, 
the stimulation was applied for 25 minutes and the intensity was raised for HF and LF-TENS, if 
needed, at minutes 10 and 20 of stimulation, based on the participant’s sensation, to account for 
nerve habituation [33,49].  
 
2.6 Data analysis  
 
To facilitate comparisons, pain intensity ratings obtained during the two-minute tonic heat 
pain test were averaged and the mean was used in subsequent analyses. The study was designed 
to detect a difference of 20 points on the CoVAS (clinically important difference [21]). To detect 
this difference in each age group, with 80% power and a 5% significance level, we determined 
that 15 young adults and 15 older adults had to be enrolled in the study (estimated standard 
deviation of 26, based on preliminary results). Given the design of the study, power calculations 
were made based on within-group analyses. Within-group analyses allowed us to determine both 
the effect of the independent variables TIME (T0, T1, T2 and T3) and CONDITION (HF-TENS, 
LF-TENS and P-TENS). Sample size was calculated using nQuery Advisor® (version 4.0., 
Statistical Solutions, Cork, Ireland). 
 
Because of the small number of subjects and since visual inspection of the histograms did 
not allow us to assume that the data were normally distributed, non-parametric tests were used. 
For each TENS treatment (HF, LF and placebo TENS), Friedman tests were used to compare the 
pain scores and the pain thresholds before, during and after TENS application (TIME variable). 
This allowed us to determine if each TENS treatment influenced pain perception. Friedman tests 
were also used to compare the pain scores and the pain thresholds across the three TENS 
treatments for the same time measure (CONDITION variable). This allowed us to directly 
compare the efficacy of HF-TENS, LF-TENS and P-TENS. Differences were considered to be 
significant if p < 0.05 was obtained. Bonferroni corrections were applied to all post-hoc multiples 
analyses to prevent for type I errors. All tests were performed using SPSS® (version 17.0 for 
Windows®, Chicago, IL, USA).  
 
 
3. Results  
 
3.1 Participants characteristics and stimulation parameters 
 
The characteristics of the participants and stimulation parameters are presented in Table 1. 
Each group was composed of 9 women and 6 men. Of the 30 participants, 6 (3 in the young 
group and 3 in the older group) identified the presence of a placebo treatment (success rate for 
blinding of 80%). 
 
3.2 Baseline pain measures 
 
The mean pain intensity ratings obtained at baseline (T0) showed that every participant 
experienced pain before TENS application (all pain intensity scores > 7). The mean thermode 
pain scores obtained before TENS application are presented in Table 2. As can be seen from the 
table, baseline pain scores were comparable for the three TENS conditions and between the two 
age groups. There was a slight difference between the two age groups for the HF-TENS 
condition. The difference did not however reach statistical (p = 0.05) or clinical significance [21]. 
 
3.3 Pain intensity 
 
 The average pain intensity scores obtained before, during and after the different TENS 
conditions in young individuals are presented in Figure 2A. Pain intensity decreased with both 
HF and LF-TENS. Friedman tests and post-hoc Wilcoxon signed-rank tests confirmed that there 
was a significant reduction in pain during (T1) and after TENS application (T2 and T3) in young 
individuals when compared to baseline for both HF and LF-TENS (all p values < 0.01). The 
reduction in pain was both statistically and clinically significant (pain reduction > 20 points [21]). 
No change was observed following P-TENS (p = 0.28). A significant difference was observed at 
T1 between HF-TENS and P-TENS, and between LF-TENS and P-TENS (all p-values ≤ 0.05). 
No difference was observed between HF-TENS and LF-TENS at T1 (p = 1.0) and between the 
three TENS conditions at T2 and T3 (all p-values > 0.29). 
 
The average pain intensity scores obtained before, during and after the different TENS 
conditions in older individuals are shown in Figure 2B. When compared to baseline, there was no 
change in pain during and after TENS application (all p-values  0.07). No significant difference 
was observed between the three TENS conditions at T1, T2 and T3 (all p-values  0.20). 
 3.5 Heat pain threshold (HPT) 
 
The HPT values obtained before, during and after TENS are presented in Table 3. In the 
young group, the Friedman tests showed that HF, LF and P-TENS all modified HPT. Post hoc 
Wilcoxon signed-rank tests revealed that HPT increased during and after HF-TENS when 
compared to baseline (all p-values < 0.01). For LF-TENS, HPT increased after (p < 0.05), but not 
during (p = 0.69) TENS application. For P-TENS, HPT increased during (p < 0.05), but not after 
(p = 0.19) TENS application. In the older group, the Friedman tests showed that LF-TENS, but 
not HF and P-TENS, altered HPT. Post-hoc Wilcoxon signed-rank tests revealed that HPT 
increased during and after LF-TENS when compared to baseline (all p-values < 0.05). 
 
3.4 Conditioning effect 
 
Because previous studies have observed that the conditioning effects provided by the 
experience of placebos can influence the results of clinical trials [2,30,31], we performed 
between-subject analyses to determine if the hypoalgesic response observed following HF and 
LF-TENS applications was influenced by the order of presentation. To do this, delta pain scores, 
representing pain reductions experienced after HF and LF-TENS applications (delta pain score = 
pain at baseline – pain after TENS), were calculated and compared between participants who 
received P-TENS during their first session and those who received HF and LF-TENS during their 
first session. The analyses revealed that the order of presentation did not influence the pattern of 
results (i.e., similar hypoalgesia following HF and LF-TENS for participants who received P-
TENS during their first visit and participants who received HF or LF-TENS during their first 
visit; p > 0.53). 
 
4. Discussion 
 
In the present study, we evaluated the hypoalgesic effect of HF, LF and P-TENS in a 
group of young and older individuals. The analyses of pain ratings obtained during the 
experimental heat pain paradigm revealed a strong and significant decrease in pain for HF and 
LF-TENS in young individuals. The important hypoalgesic effect noted in young adults contrasts 
with the absence of hypoalgesic effect noted in older participants. In this latter group, there was 
no change in pain for both HF and LF-TENS, indicating that neither one of these TENS 
stimulation paradigms is effective for reducing experimental pain in elderly individuals.  
 
4.1 TENS effect in young individuals 
 
 Many of the previous studies looking into the hypoalgesic effect of TENS were done with 
young or age-heterogeneous populations. For example, in their study, Chesterton et al. [12], 
evaluated the effect of HF and LF-TENS on mechanical pain thresholds in a group of 240 healthy 
young subjects (mean age = 30 ± 7 years old). The authors reported that HF and LF-TENS 
similarly increased pain thresholds, suggesting that these two TENS stimulation protocols are 
effective for reducing pain in young adults. These results somewhat contrast with the results of 
Chen & Johnson [11], who noted a greater effect on mechanical pain thresholds for HF-TENS 
compared to LF-TENS. In opposition to Chesterton et al. [12] (who applied LF-TENS at a 
strong/to tolerance intensity level) Chen & Johnson [11] applied LF-TENS at a low/non-painful 
intensity level. We believe that LF-TENS should be applied at strong/painful stimulation 
intensities [13,40,62][62]. 
 To our knowledge, six studies have evaluated the effect of TENS using experimental heat 
pain paradigms [8,32,48,57,58,60]. Although the quality of these studies was generally low, the 
vast majority (5 studies out of 6) found positive effects of TENS (see for instance Claydon et al. 
[13] for a commendable review on the effect of TENS on experimental pain). The hypoalgesic 
effect of TENS has also been studied directly in clinical pain populations, with some studies 
showing positive [37,41] and other studies showing negative [15] results. In 2007, Jonhson & 
Martinson [24] performed a large meta-analysis – regrouping 38 studies with various 
musculoskeletal pain populations – to determine if the hypoalgesic effect of TENS is superior to 
that of placebo. The meta-analysis showed that TENS is more effective than placebo, with the 
authors suggesting that the equivocal results reported in previous studies may have been due to 
insufficient statistical power. 
 
4.2 TENS effect in old individuals 
 To our knowledge, very few studies have specifically looked into the hypoalgesic effect 
of TENS in elderly individuals (see for instance [22,47]). In their studies, Grant et al. [22] and Ng 
et al. [47] both reported positive effects of TENS on pain in older patients. Yet, it is important to 
note that the studies of Grant et al. [22] and Ng et al.
 
[47] did not include a placebo condition. It 
is therefore impossible to determine if the effect observed following TENS application by these 
authors is attributable to an active treatment component [4].  
 
The present results – in particular the ones regarding the absence of hypoalgesic effect of 
LF-TENS in older individuals – are in line with the results of Edwards & Fillingim [16] and of 
Lariviere et al. [27] who observed reduced efficacy of descending pain inhibition in older 
individuals compared to young individuals. Indeed, it should be kept in mind that the hypoalgesic 
effect of LF-TENS depends on the activation of descending pain modulating mechanisms 
originating from the brainstem [20,25,39,62]. The results of the present study confirm and extend 
the results of Edwards et al.[17] and Larivière et al.[27] by showing that the efficacy of 
descending and segmental pain mechanisms are affected in older individuals.  
 
4.3 Effect of TENS on heat pain thresholds 
 
 Previous reports have shown that HF and LF-TENS can increase pain threshold (including 
HPT [8], cold pain threshold [10] and mechanical pain threshold [12,57]. In this study, we 
observed an increased HPT with HF, LF, and P-TENS in young participants and an increase in 
HPT with LF-TENS (but not with HF and P-TENS) in older participants. Although our 
observations are somewhat in line with the results of Cheing et al. [8] (who observed increased 
HPT in young individuals following HF and LF-TENS) and with the results of Chesterton et al. 
[12] (who observed increased pain thresholds in young individuals following HF and LF-TENS), 
it remains difficult to explain why the results obtained with HPT differ from those obtained with 
the tonic heat pain test. These discrepancies can probably be explained by the different 
mechanisms involved. For instance, detection of HPT is believed to rely on the activity of A-delta 
fibers, while the pain experienced during tonic nociceptive stimuli mostly depends on C-fibers 
activation [40]. The results obtained from a study by Naert et al.[46], who observed that tonic 
heat pain ratings only moderately correlated with HPT, support such an interpretation.  
 
4.4 Increased baseline pain scores 
 
 Although non-significant, analysis of baseline pain scores revealed that elderly 
participants tended to experience slightly higher pain before TENS application compared to 
young participants. In a past research report, Benedetti and colleagues showed that baseline pain 
scores could affect TENS efficacy. In their study, Benedetti et al. noted a positive effect of TENS 
for patients with mild or moderate pain, but not for those with severe pain. These results suggest 
that high pain levels can negatively affect TENS efficacy. In the present study, we observed that 
the hypoalgesic effect of HF-TENS observed in young individuals was absent in older individuals 
despite the fact that the later reported slightly lower baseline pain scores than the former. Hence, 
the group difference in baseline pain scores does not jeopardize the conclusions regarding the 
absent TENS response noted in elderly individuals. 
 
4.5 Potential neurophysiological mechanisms 
 
 The hypoalgesic effect of TENS depends on the activation of opioid and non-opioid 
circuits located at the spinal and supraspinal level [25,30,39,44,56]. Some authors have reported 
significant age-related changes in these spinal [35,36] and supra-spinal circuits [26,34]. For 
instance, Hoskins and colleagues observed reduced spinal opioid-induced antinociception 
responses in older rats [35], a finding that could be explained by the age-related changes in the 
affinity of spinal opioid receptors [36]. Taken together, these findings could help to explain the 
blunted TENS response observed in elderly individuals. Future research is necessary to better 
understand the neurophysiological mechanisms underlying the results observed in this study. 
 
4.6 Limitations 
 
One potential limitation that could be addressed to the present study is the use of an 
experimental pain paradigm rather than a clinical pain paradigm. Without refuting the fact that 
experimental pain paradigms have less external validity than clinical pain paradigms, the former 
has, on the counterpart, the advantage of increasing internal validity. For example, in the present 
study, using an experimental pain paradigm allowed us to evaluate the hypoalgesic effect of 
TENS in young and older individuals who experienced comparable pain (i.e., nociceptive/thermal 
pain, moderate intensity level). We believe that recruiting young and older participants with 
similar pain conditions and profiles would have been a very difficult, if not impossible task. 
Having two groups of participants with different pain profiles would certainly have reduced our 
ability to make clear assertions regarding the similarities/differences of young and older 
individuals. Nevertheless, we must keep in mind that the results of the present study cannot be 
directly generalized to clinical pain conditions. More studies need to be conducted in pain 
populations before any definitive conclusion can be made regarding the effect of TENS in the 
elderly. 
 
 Another important limitation concerns the relatively low statistical power observed for the 
older group. Indeed, contrarily to the analyses for the young group (73% < 1 - β < 100%), the 
analyses made in the older group reached a statistical power situated between 10 and 65%. This 
situation can be explained by the high variability of pain responses measured in older 
participants, a situation which has also been reported for other types of measures [43,64]. The 
lower statistical power observed in the older group increases the chances of the occurrence of a 
type II error. However, one has to remember that the hypoalgesic response observed in older 
participants was not clinically significant (reduction in pain scores < 20 points). Therefore, even 
if statistically significant, the reduction in pain observed in elderly individuals following HF and 
LF-TENS would have been of little clinical importance.  
 
5. Conclusion 
 
In the present study, we demonstrated that elderly individuals do not respond to TENS as 
well as young adults. In particular, we observed that, although effective for reducing pain in 
young adults, both HF and LF-TENS did not significantly reduce pain ratings in the elderly. 
These observations can offer possible explanations for the contradictory results that are 
sometimes observed in the literature concerning TENS effectiveness. Clearly, more studies 
should be conducted to confirm the present results in pain populations and to identify strategies 
that could enhance TENS hypoalgesia in the elderly. 
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Figure Legend 
 
Figure 1. TENS application 
 
Figure 2. Pain intensity before (T0), during (T1), immediately after (T2) and 30 minutes after 
TENS application (T3) in young (A) and older (B) participants. When compared to baseline, 
there was a significant reduction in pain during and after HF and LF-TENS in young (all p values 
≤ 0.01) but not in older individuals (all p-values ≥ 0.1). For the young group, a significant 
difference was observed at T1 between HF-TENS and P-TENS, and between LF-TENS and P-
TENS (all p-values ≤ 0.05). No significant difference was observed between the three TENS 
conditions in the older group (all p-values > 0.20). 
 
 
 
 
 
